Gilder Gagnon Howe & Co’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History
Bought
Maintained
Sold
Other funds holding RNA
A
DM
VLKIM
SFM
BA
ARTA
BG
Gilder Gagnon Howe & Co's RNA Position: Q4 2013 in Review
Gilder Gagnon Howe & Co sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q4 2013, closing a stake of 12,335 shares — an estimated $82K sold.
Gilder Gagnon Howe & Co first reported a position in RNA in Q3 2013 and held it in 1 quarter. The position peaked at $82K in Q3 2013. 22 funds tracked by Wall St. Rank hold RNA as of Q4 2013.
- Gilder Gagnon Howe & Co reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q4 2013 after selling out during the quarter.
- Gilder Gagnon Howe & Co sold 12,335 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q4 2013, an estimated $82K.
- Gilder Gagnon Howe & Co first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2013 and held it in 1 quarter.
- Gilder Gagnon Howe & Co's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $82K in Q3 2013.
- 22 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q4 2013.
Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2013, filed 14 Feb 2014.